Brain and Skin Involvement in Erdheim-Chester Disease
Neurol 96:e1590-e1592, Budhram, A.,et al, 2021
Clinical and Neuroimaging Findings in MOGAD-MRI and OCT
Clin Exp Immunol 206:266-281, Bartels,F.,et al, 2021
Utility of MRI Enhancement Pattern in Myelopathies with Longitudinally Extensive T2 Lesions
Neurol Clin Pract 11:e601-e611, Mustafa,K.,et al, 2021
Catastrophic Cerebral Fat Embolism Syndrome Lacks Hyperacute MRI Findings
Neurol: Clin Pract 6:e962-e964, Gusler, M.T.,et al, 2021
"Disappearing Infarct" Is Late-Onset MELAS
Ann Neurol 90:1001-1002, Landis,T.M.,et al, 2021
Unilateral PRimary Angiitis of the Central Nervous System
Ann Neurol 90:999-1000, Santyr,B.,et al, 2021
Clinicopathologic Conference, Fat Embolism Syndrome
NEJM 385:2464-2474, Case 39-2021, 2021
A 64-Year-Old Man with Multiple Cranial Neuropathies
Neurol 97:e215-e221, Lefland, A.,et al, 2021
Imaging Patterns Characterizing Mitochondrial Leukodystrophies
AJNR 42:1334-1340, Roosendaal, S.D.,et al, 2021
COVID-19-Associated PRES-like Encephalopathy with Perivascular Gadolinium Enhancement
AJNR 41:2206-2208, Conte, G.,et al, 2020
The role of infarct location in patients with DWI-ASPECTS 0-5 acute stroke treated with thrombectomy
Neurol 95:e3344-e3354,1078, Panni, P.,et al, 2020
Immunocompetent Patient with Multiple Cranial Nerve Palsies, Ataxia, and Cognitive Decline
Neurol 94:e225-e229, Nigam, M.,et al, 2020
Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome
Neurol 95:e268-e279, Keddie, S.,et al, 2020
A Patient with a History of Weight Loss Presenting with Seizures
Neurol 95:e2038-e2042, Tang, G. & Benavides, D.R., 2020
Fat Embolism Syndrome in Sickle Cell Disease
J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020
Acute Cortical Lesions in MELAS Syndrome: Anatomic Distribution, Symmetry, and Evolution
AJNR 41:167-173, Bhatia,K.D.,et al, 2020
Three Territory Sign
Neurol Clin Pract 9:124-128, Nouh, A.M.,et al, 2019
A Woman in her 40s with Transient Neurological Symptoms, Migraine Headaches, and Hearing Loss
JAMA Neurol 76:504-505, Roshal, D.A.,et al, 2019
"Better Explanations" in Multiple Sclerosis Diagnostic Workup
Neurol 92:e2527-e2537, Calabrese, M.,et al, 2019
Imaging Features (CT, MRI, MRS, PET/CT) of Primary Central Nervous System Lymphoma in Immunocompetent Patients
Neurol Sci 40:535-542, Cheng, G. & Zhang, J., 2019
Mapping the Supratentorial Cerebral Arterial Territories Using 1160 Large Artery Infarcts
JAMA Neurol 76:72-80, Kim, D-E.,et al, 2019
Basa Ganglia Calcifications (Fahrs Syndrome): Related Conditions and Clinical Features
Neurol Sci 40:2251-2263, Donzuso,G.,et al, 2019
Diagnostic Tools for Immune Causes of Encephalitis
Clin Microbiol Infect 25:431-436, Lascano, A.M.,et al, 2019
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
NEJM 379:1017-1027, Chitnis, T.,et al, 2018
Surviving Cerebral Malaria
Neurol 91:978-979, Wijdicks, E.F.M. & Park, J.G., 2018
Distinct Brain Microhemorrhage Pattern in Critical Illness Associated with Respiratory Failure
Neurol 90:e2011, Hall, J.P.,et al, 2018
Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018
Mixed-Location Cerebral Hemorrhage/Microbleeds
Neurol 90:e119-e126, Pasi, M.,et al, 2018
Gasperini Syndrome
Neurol 90:e261, Lorio, R., 2018
Supplementary Motor Area Stroke Mimicking Functional Disorder
Stroke 49:e28-e30, Mathew, P.,et al, 2018
Cerebral Fat Embolism Syndrome in Sickle Cell Disease Without Evidence of Shunt
eNeurologicSci 14:19-20, Nathan, C.L.,et al, 2018
Intracranial Meningeal Enhancement Characterization
Rev Colomb Radiol 28:4709-4716, Mera, J.L.C.,et al, 2017
Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017
Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017
Evolution of DWI lesions in Cerebral Amyloid Angiopathy
Neurol 89:2136-2142, Van Veluw, S.J.,et al, 2017
Imaging Characteristics of Venous Parenchymal Abnormalities
Stroke 48:3258-3265, Arnoux, A.,et al, 2017
Glial Fibrillary Acidic Protein Immunoglobulin G as Biomarker of Autoimmune Astrocytopathy: Analysis of 102 Patients
Ann Neurol 81:298-309, Flanagan, E.P.,et al, 2017
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017
Have Clinicians Adopted the Use of Brain MRI for Patients with TIA and Minor Stroke?
Neurol 88:237-244, Chaturvedi, S.,et al, 2017
Characteristics in Limbic Encephalitis with Anti-Adenylate Kinase 5 Autoantibodies
Neurol 88:514-524,508, Do, L. & Chanson, E., 2017
Diagnosis of Multiple Sclerosis: Progress and Challenges
Lancet 389:1336-1346, Brownlee, W.J.,et al, 2017
Primary Angiitis of the Central Nervous System
Stroke 48:1248-1255, Boulouis, G.,et al, 2017
Distribution of Lacunes in Cerebral Amyloid Angiopathy and Hypertensive Small Vessel Disease
Neurol 88:2162-2168, Pasi, M.,et al, 2017
Neurologic Signs and Symptoms Frequently Manifest in Acute HIV Infection
Neurol 87:148-154, Hellmuth, J.,et al, 2016
Clinicopathologic Conference, Somnolence due to the Cerebral Fat Embolism Syndrome
NEJM 375:370-378, Case 23-2016, 2016
Herpes Simplex Encephalitis in an Immunocompromised Adult with Novel MRI and Pathology Findings
Clin Neuroradiol DOI: 10.1007/s00062-016-0536-x, Modak, J.,et al, 2016
Central Canal Enhancement and the Trident Sign in Spinal Cord Sarcoidosis
Neurol 87:743-744, Zalewski, N.L.,et al, 2016
The Contemporary Spectrum of Multiple Sclerosis Misdiagnosis
Neurol 87:1393-1399, Solomon, A.J.,et al, 2016
Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016